Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Pre-Interphex 2010 Product Releases.

Pharmaceutical Technology
Volume 34, Issue 3, pp. 83-87



Sterile connector
The 1-in. Pure-Fit SC sterile connector is designed with the same features as Saint-Gobain's other connectors, but in a large, versatile size for great flow volume. The silicone valve design allows easy assembly, and the patented Pure-Fit SIB technology is designed to ensure a smooth inner bore. Saint-Gobain Performance Plastics, Clearwater, FL http://www.biopharm.saint-gobain.com/ tel. 800.541.6880



Visual inspection system
Eisai Machinery USA offers semiautomatic, semimanual, and manual VIS visual inspection systems. Eisai provides validation expertise to help implement VIS 1000 semiautomatic inspection machines. The company also provides a program of continuous service and technical support for its clients. The program monitors clients' machines to reduce downtime and improve production-line efficiency. Eisai Machinery USA, Hackensack, NJ http://www.eisaiusa.com/ tel.201.746.2111



Quality-control system
The FS-80 IP system reliably detects improperly sealed cans and twist-off bottle caps. The system improves final-product quality on assembly lines that fill containers under vacuum or pressure, including nitrogen-dosed cans, and it reliably detects low vacuum or pressure at speeds as high as 1300 bottles/min or 2000 cans/min. Industrial Dynamics/filtec, Torrance, CA http://www.filtec.com/ tel. 888.434.5832



Dual-shaft change-can mixers
Ross's dual-shaft change-can mixers each include an anchor and a high-speed disperser. Each agitator is driven independently by an inverter-duty, explosion-proof motor to enable variable-speed operation. Mixers are available in 2-, 10-, 50-, 100-, and 200-gal sizes. Change-can models are available in 2–1000-gal sizes. Charles Ross and Son, Hauppauge, NY http://mixers.com/ tel. 800.243.ROSS


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here